{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:58:23Z","timestamp":1786118303504,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Oncology"],"published-print":{"date-parts":[[1993,9]]},"DOI":"10.1097\/00001622-199309000-00007","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T04:52:16Z","timestamp":1163134336000},"page":"812-818","source":"Crossref","is-referenced-by-count":5,"title":["Cutaneous T-cell lymphomas"],"prefix":"10.1097","volume":"5","author":[{"given":"Edward H.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001622-199309000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:25:39Z","timestamp":1786029939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-199309000-00007"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1993,9]]},"references-count":0,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1097\/00001622-199309000-00007","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[1993,9]]}}}